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AIDS-associated cholangiopathy is a form of biliary tract inﬂammation with stricture formation seen in AIDS patients who
are severely immunosuppressed. It is no longer common in countries in which HAART therapy is widely employed but is still
seen in underdeveloped countries. The majority of patients are symptomatic at the time of presentation. Herein, we describe
a seventy-four-year-old woman who presented with unilateral leg swelling after a prolonged airplane ﬂight. She was otherwise
entirely asymptomatic. Routine laboratory testing was notable for a hypochromic microcytic anemia, slight leukopenia, and mild
hypoalbuminemia. Liver enzymes were all elevated. Deep venous thrombosis was conﬁrmed, and a CT scan of the chest disclosed
no pulmonary emboli. However, the visualized portion of the abdomen showed dilatation of the common bile and pancreatic
ducts. This was conﬁrmed on ultrasonography and MRCP, and no obstructive lesions were noted. An ERCP revealed a dilated
common bile duct without ﬁlling defects or strictures. A balloon occlusion cholangiogram showed strictures and beading of the
intrahepatic ducts. Shortly thereafter, serology for HIV returned positive along with a depressed CD4 cell count, and the patient
was diagnosed with AIDS-associated cholangiography.
1.CasePresentation
A seventy-four-year-old Kenyan woman was admitted to the
hospital with bilateral lower extremity edema. Three days
earlier, she had arrived to the United States after a sixteen
hour ﬂight. Past medical history included a stroke with
no residual deﬁcits and chronic low-back pain. Her family
history was unremarkable. The patient had a 30 pack-
year history of smoking but had quit 3 years earlier. She
neither drank nor used illicit drugs. Review of systems was
notable for generalized pruritus without rash, a periodic
nonproductive cough, dysphagia with globus sensation, and
a recent unintended weight loss of 14kg. She had not been
sexually active in more than thirty years.
Her vital signs included a temperature of 36◦C, blood
pressure 104/68mmHg, respiratory rate of 16 per minute,
heartrate80perminute,andO2 saturation98%onroomair.
The initial physical exam was only remarkable for 2+ edema
in the left lower extremity as well as bilaterally diminished
lung sounds with occasional faint late inspiratory crackles at
the bases.
Abnormal “routine” laboratory tests included hemoglo-
bin 99g/L, hematocrit 0.32vol RBC/vol whole blood, WBC
count 3,400/cc, 8% eosinophils, MCV 66fL, and albumin
32g/L; liver enzyme panel revealed an AST of 79U/L (nor-
mal: 7–40U/L), ALT of 67U/L (normal: 7–40U/L), alkaline
phosphatase of 252U/L (normal: 30–136U/L),and GGTP of
287U/L(normal: 8–78U/L).The bilirubin and prothrombin
time were normal. A venous duplex of the lower extremities
revealed a thrombus in the left superﬁcial femoral vein
extending into the left popliteal vein. She was placed on he-
parin and warfarin.
An initial chest X-ray evealed a right lower lobe patchy
inﬁltrate versus atelectasis. Given her history of cough and
weight loss, the patient was treated with ceftriaxone and
azithromycin for possible pneumonia and placed on droplet2 International Journal of Hepatology
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precautions while a PPD was placed and a QuantiFERON
Gold lab test was obtained. Written consent was also
obtained to complete an HIV test.
A CT scan of the chest showed no signiﬁcant pulmo-
nary pathology or embolism. The visualized portion of
the abdomen showed dilatation of the common bile and
pancreatic ducts. An abdominal ultrasound later conﬁrmed
dilatationofthecommonbileductandshowed centralintra-
hepaticductdilatation aswell. Nostoneswere visualized, but
the distal portion of the common bile duct was obscured
by overlying bowel gas. Magnetic resonance cholangiopan-
creatography (MRCP) showed pancreatic and biliary ductal
dilatation without identiﬁcation of any obstructive lesions.
(Figure 1). An ERCP revealed a dilated common bile duct
without ﬁlling defects or strictures. It was, however, very
diﬃcult to ﬁll up the intrahepatic ducts. A 15mm balloon
occlusion cholangiogram was, therefore, performed and
showed strictures and beading of the intrahepatic ducts.
(Figure 2) The patient was felt to have sclerosing cholangitis,
and was started on ursodiol 300mg three times daily.
Shortly thereafter, the patient’s HIV test came back
positive. The CD count was 124 per cubicmillimeter with an
HIV viral load of 2.6 million copies/mL. As it was suspected
that the patient suﬀered from AIDS cholangiopathy, further
laboratory studies were obtained. A stool study for Isospora
ovaandparasitesandadirectstoolstudyforCyclosporawere
negative. An electroimmunoﬂuroscent assay for cryptospora
was also negative. The IgM level of CMV antibody was
0.34 (nl: <0.91 antibody index; equivocal 0.91–1.09; positive
>1.09), but the IgG level of CMV antibody was elevated at
4.74 antibody index.
2.Discussion
The term “AIDS cholangiopathy” (aka AIDS-related cholan-
gitis) was ﬁrst coined in 1986 by Margulis et al. who
described biliary tract abnormalities in patients with AIDS
[1]. However,in1983,Guarda etal. had previously described
two cases of cryptosporidiosis in patients with the acquired
immune deﬁciency syndrome, one of whom had gallbladder
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involvement [2]. That same year, Pitlik et al. described two
patients with biliary papillary stenosis who suﬀered from
cryptosporidiosis [3]. In early studies, AIDS cholangiopathy
was estimated to occur in up to 26 percent of AIDS patients,
but its true incidence is unknown as many patients are
asymptomatic. No prevalence studies have been published,
but in the 1990s the prevalence was estimated to be as
high as 30% in patients with chronic AIDS-related diarrhea
[4]. Since the advent of highly active antiretroviral therapy
(HAART) it has become less common in the United States,
but in areas with limited access to healthcare such as Kenya,
it may be as high as 45% [5]. AIDS cholangiopathy is usually
seen in patients with CD4 counts below 100/mm3 [6]. It
usually presents in patients with a known diagnosis of HIV,
but it can rarely present as an AIDS-deﬁning illness [7].
The etiology of AIDS cholangiopathy is unknown, but
it is believed to be related to opportunistic infections in the
biliarytractwherepathogenshaveoftenbeendetected.These
infections likely cause a secondary sclerosing cholangitis due
to the associated continual inﬂammation. It is theorized that
enteric infection leads to portal bacteremia which, in turn,
leads to subsequent bile duct injury and destruction [8].
HIV itself may play a role in some manifestations of AIDS
cholangiopathy. However, although it has been isolated in
the bowel mucosa, it has never been detected in the biliary
epithelium. A genetic predisposition has been postulated as
pathogens may trigger an autoimmune-mediated reaction
in patients with HLA DRw52a [8]. This may explain why
the features of AIDS cholangiopathy are independent of the
associated opportunistic infection [9].
The pathogens associated with AIDS cholangiopathy are
listed in Table 1. AIDS cholangiopathy is usually associated
withbacterialorMycobacteriumtuberculosisinfectionwhen
the CD4 count ranges from 200 to 750 cells per cubic
mm. With CD4 counts less than 200 cells per cubic mm,
associated infections are viral,protozoan orfungal, orcausedInternational Journal of Hepatology 3
by Mycobacterium avium intracellulare [10]. The two most
commonly detected pathogens are Cryptosporidium and
cytomegalovirus (CMV). When there is involvement of the
intrahepatic ducts, Cryptosporidium and CMV infection are
morelikelythanwhentheintrahepaticductsarenotinvolved
[10].
Cryptosporidium was the ﬁrst opportunistic infection
reported in the bile ducts of AIDS patients in 1983 by two
independent groups, Pitlik et al. [3] and Benhamou et al.
[11]. It is also a common opportunistic infection in AIDS
cholangiopathy detected in 6% of AIDS patients in the pre-
HAART era and in 21% of those with diarrhea [12]. During
the cryptosporidiosis outbreak in Milwaukee’s municipal
water supply in 1993, four-hundred thousand people were
exposed to cryptosporidiosis, and 29% of AIDS patients that
developed cryptosporidiosis had biliary tract involvement.
AIDS patients with CD4 counts less than 50 per cubic
millimeter were more likely to have biliary symptoms and
an increased risk of death at one year [13]. Cryptosporidium
is associated with severe and diﬀuse changes in the biliary
tract. It initiates an inﬂammatory response that is mostly
composed of lymphocytes with occasional plasma cells and
macrophages and rare eosinophils. Neutrophils can be seen
in the lumina of dilated glands forming microabscesses. The
cells of the biliary epithelium often have enlarged nuclei
with an eosinophilic cytoplasm and are transformed into
cuboidal or attenuated cells [14]. Squamous metaplasia can
also occur [15]. Polypoid defects have been hypothesized
to be caused by granulation tissue that extends into the
bile ducts [16]. Cryptosporidium parvum has also been
linked to the development of sclerosing cholangitis in other
immunocompromised patients such as those with X-linked
hyper IgM syndrome [5].
Before the introduction of HAART therapy, cytomega-
lovirus was detected in up to two-thirds of autopsies
in AIDS patients. These patients often had coinfection
with Cryptosporidium and Candida albicans. Common bile
duct dilatation and a mural thickening of an acalculous
gallbladder were often noted [5]. It has been suggested
that cytomegalovirus could lead to ischemic injury of the
biliary tract in a fashion similar to that in posttransplant
patients and patients undergoing intraarterial chemotherapy
who develop bile duct injury that resembles sclerosing
cholangitis. The inclusion bodies that are characteristic of
cytomegalovirus infection are rarely seen in biliary epithelial
cells of aﬀected patients, but are frequently found in the
arteriole adjacent to the biliary duct [17]. Often there is an
associated lymphocytic inﬁltrate [7]. Viral cultures for CMV
are usually negative but immunohistochemical stains may
improve CMV detection [6]. In situ DNA hybridization is
the method of choice for detecting CMV in tissue samples
[18]. Microsporidia is uncommon in patients with AIDS
cholangiopathy. In a study by Ko et al., it was not identiﬁed
in any of the patients with AIDS cholangiopathy [19].
However, there have been other reports that identiﬁed the
organism although in fewer than 10% of patients [6]. It
had beensuggested that patientswith no identiﬁed pathogen
may have microsporidial infection as multiple biopsies are
often required for its detection. Enterocytozoon bieneusi
can be detected with hematoxylin and eosin stain, but is
more apparent with Giemsa stain. In some cases, electron
microscopy maybenecessary [6,20].Isospora andMycobac-
teriumaviumintracellulare(MAI)arelesscommoncausesof
AIDS cholangiopathy contributing to fewer than 5% of cases
[7]. Mycobacterium avium complex is a consideration when
one sees poorly formed noncaseating granulomas along with
large foamy macrophagesand a scarcity oflymphocytes[21].
Malignancies such as Kaposi’s sarcoma or primary Burkitt’s
lymphoma can also cause AIDS cholangiopathy, but this is
far less common than an infectious etiology [7, 21]. Finally,
diseases of the pancreas that involve the distal common bile
duct can mimic AIDS cholangiopathy [21].
Aﬀectedpatientsoftenpresentwithrightupperquadrant
abdominal pain (99%) and, less commonly, with fever and
jaundice (10%) [4]. Abdominal pain is typically more severe
when papillary stenosis is present [5]. It is characteristically
sharp in nature and may radiate to the back. Nausea and
vomiting are not uncommon [22]. Fever occurs in over
half of patients with AIDS cholangiopathy, and high spiking
fevers can indicate a bacterial superinfection [7]. Patients
who are infected with cryptosporidium, microsporidium
or MAI additionally may have diarrhea and malabsorption
symptoms [7, 22].
Laboratory examination is helpful but not speciﬁc in
the diagnosis of AIDScholangiopathy. The classic laboratory
proﬁle in AIDS cholangiopathy is an alkaline phosphatase
that is ﬁve- to seven-times the upper limit of normal and
a moderate increase in transaminase levels. Alkaline phos-
phatase elevation may be the sole laboratory abnormality in
some patients. Jaundice in AIDS cholangiopathy is usually
mild with a total bilirubin less than twice the upper limit of
normal indicating incomplete obstruction. In approximately
20% of patients with AIDS cholangiopathy, however, all
aforementioned lab tests are within normal limits even with
diagnostic ﬁndings on ERCP [5]. Amylase levels may be
elevated in 10% of patients [7].
Ultrasonography is useful in the initial screening of
AIDS cholangiopathy as it can provide the intraluminal
caliber, thickness of the gallbladder wall and bile ducts, the
presence of stones, sludge and/or pericholecystic ﬂuid [23].
It is abnormal in approximately 75% of patients with AIDS
cholangiopathy [7]. Earlier studies indicated that up to 25%
patients with AIDScholangiopathy have normal ultrasounds
especially if the disease is isolated to the intrahepatic ducts
[21], but larger more recent studies suggest that ERCP
adds little beneﬁt, as ultrasound has a sensitivity of 97%
and a speciﬁcity of 100% [24]. Endoscopic ultrasound
allows for better detection of dilation and thickening of the
common bile duct and can more accurately exclude stones,
extrabiliary compression, and tumors when compared to
transabdominal ultrasound [11].
CT is more useful than ultrasound in identifying intra-
hepatic strictures [7]. It is also better at disclosing abnor-
malities of the pancreas and liver [9]. However, it is less
successful than ultrasound in demonstrating wall thickening
and strictures of the common bile duct [7]. Radionuclide
hepatobiliaryscanning(HIDA)candetectductdilatationbut
has been supplanted by other imaging modalities. It may be4 International Journal of Hepatology
Table 1: Infectious causes of AIDS-associated cholangiopathy.
Bacteria, Mycobacteria Viruses Protozoa Fungi
Mycobacterium avium-intracellulare
Mycobacterium kansasii
Mycobacterium tuberculosis
Rochalimaea henselae
Rochalimaea quintana
Salmonella enteritidis
Salmonella typhimurium
Enterobacter cloacae
Campylobacter fetus
Cytomegalovirus
Herpes simplex
Adenovirus
HIV
Pneumocystis carinii
Microsporidia
Enterocytozoon bieneusi
Encephalitozoon cuniculi
Encephalitozoon intestinalis
Cryptosporidium parvum
Leishmania donovani
Toxoplasma gondii
Dicrocoelium dendriticum
Cyclospora cayetanensis
Isospora
Histoplasma capsulatum
Cryptococcus neoformans
Coccidioides immitis
Candida albicans
Table 2: Imaging features of AIDS cholangiopathy versus primary sclerosing cholangitis.
AIDS cholangiopathy Primary sclerosingcholangitis
Dilation commonbile duct Common Rare
Intrahepatic ducts Aﬀected but usually normal in number Signiﬁcantlydecreased in number
Intraductal debris Common Rare
Intraductal ﬁlling defects Yes None
String-like strictures Rare Common
Diverticular outpouchings and
sacculations Rare Common
Papillary stenosis + intrahepatic ductal
stricture Common Never reported
Extrahepatic stricture morphology Irregular margins and nodules reﬂecting an
often focal nature
Irregular strictures with entire ducts
involved
Gallbladder wall thickening Common Rare
a useful in patients suspected of having acute cholecystitis.
Of note is the fact that 20% of patients will have normal
noninvasive imaging studies [4]. The gold standard for
diagnosing AIDS cholangiopathy is by direct visualization of
the biliary tracts via ERCP [8]. Biliary brushings or aspirated
biliary ﬂuid may help make the diagnosis of Cryptosporid-
ium or Microsporidia. ERCP is useful in obtaining biopsy
samples and for testing for CMV, Cryptosporidium, and
M y c o p l a s m a .I ti sa l s op a r t i c u l a r l yu s e f u li np a t i e n t sw i t h
severe pain, allowing for sphincterotomy. ERCP has not
been recommended in patients with asymptomatic AIDS
cholangiopathy [21].
Four subcategories of AIDS cholangiopathy have been
described: (1) papillary stenosis (15%), (2) intrahepatic scle-
rosing cholangitis-like lesions (20%), (3) a combination
of papillary stenosis and intrahepatic sclerosing lesions
(50%), and (4) long extrahepatic bile duct strictures with
or without intrahepatic lesions (15%) [4]. Papillary stenosis
is deﬁned as a common bile duct diameter of >8mmwith
tapering of the distal 2–4mm of the common bile duct
with marked retention of contrast beyond 30 minutes. It
is unknown if the diﬀerent subtypes are a continuum of
one disease process [21]. The common bile duct can have a
beaded or scalloped appearance. The left intrahepatic ductal
system is more severely involved than the right side in
most cases. In up to 25% of cases, intraluminal polypoid
defects are seen in the common bile duct and/or the large
intrahepatic strictures [7]. The combination of papillary
stenosis and intrahepatic ductalstrictures isrelatively unique
toAIDScholangiopathy [5].InHIV-infected individuals, the
presence of an echogenic nodule in the distal common bile
duct may indicate AIDS cholangiopathy, as it is thought to
represent edema in the papilla of Vater [25].
The intrahepatic ﬁndings in AIDS cholangiopathy are
comparable to those seen in primary sclerosing cholangitis
(PSC) with a beaded appearance and a diminished arboriza-
tion or pruning of peripheral branches. However, the extra-
hepatic manifestations of AIDS cholangiopathy are quite
diﬀerent from PSC (Table 2). Diverticular outpouchings,
sacculations, and high-grade proximal strictures are seen in
PSC while moderate ductal dilatation with irregular margins
and nodules are more characteristic of AIDS cholangiopathy
[9]. Isolated dilatation of intrahepatic biliary ducts in AIDS
cholangiopathy (i.e., Caroli disease) is very uncommon but
has been reported [8]. MRCP may be an alternative for
patients with high CD4 counts that are receiving HAART
therapy as they do not require biopsy specimens to test for
opportunistic infections [18]. In our patient, MRCP showed
a dilated common bile duct and subtle irregularities of the
intrahepatic ducts. In general, percutaneous liver biopsy has
little value in diagnosing AIDS cholangiopathy [21, 26].
Inadditiontoimagingfeatures,biopsywill oftenshowan
inﬂammatory inﬁltrate that is rich in T4 lymphocytes in pri-
mary sclersoing cholangitis while these cells are depleted inInternational Journal of Hepatology 5
AIDS patients. The characteristic ﬁnding on biopsy in AIDS
cholangiopathy is prominent mucosal folds which indicate
inﬂammation and edema. This mucosal thickening can be
diﬀuse or it can be focal in which case it is ﬁne and nodular
[9]. Approximately 26% of patients with AIDS cholangiopa-
thy have AIDS-related polypoidcholangitis which consists of
intraluminal polypoid defects within the common bile duct
andthelargerintrahepaticducts.Histologically,thepolypoid
defects correlate with the presence of granulation tissue and
do not aﬀect Prognosis [16].
Treatment of AIDS cholangiopathy is primarily endo-
scopic sphincterotomy for papillary stenosis and stenting
for dominant common bile duct strictures. Sphincterotomy
provides persistent pain relief, but unfortunately has not
been shown to prolong survival or improve transaminase
elevation [5]. Alkaline phosphatase levels continue to rise
as intrahepatic bile duct sclerosis progresses [20]. 21 One
option for pain that is refractory to endoscopic therapy
is CT-guided celiac plexus blockade [5]. For patients with
intrahepatic and extrahepatic sclerosing cholangitis treat-
ment options are limited. Although AIDS cholangiopathy is
most commonly caused by opportunistic infections, medical
treatment against C. Parvum, CMV, ormicrosporidium does
not alter symptoms or anatomical abnormalities already
present [5]. However, it is still important to treat patients for
any detected infections to prevent nonhepatic complications
such as gastrointestinal symptoms from Cryptosporidium
or retinitis from Cytomegalovirus. Many patients also have
improvement in symptoms after initiation of antiretroviral
therapy [27].
Ursodeoxycholic acid has been used in patients with
AIDS cholangiopathy, given that the intrahepatic changes
are similar to those found in primary sclerosing cholangitis.
It has been shown to improve liver biochemistry. The
recommended dose is 300mg three times daily primarily for
patients with intrahepatic ductal disease and elevated liver
function tests. Patients with pain refractory to ECP may
experience relief with ursodeoxycholic acid [28].
In the pre-HAARTera, the survival of patient with AIDS
cholangiopathy had been generally dictated by the natural
course of AIDS rather than the cholangiopathy since this
disease tends to occur in patients with advanced AIDS.
AIDS cholangiopathy was, itself, rarely fatal as other AIDS-
related illnesses were usually the cause of death in these
patients. In patients diagnosed with AIDS cholangiopathy
before the introduction of HAART, the median survival
time was 5–8 months compared to the 14 months median
survival for those diagnosed with AIDS cholangiopathy
after 1996 [19]. CD4 lymphocyte counts, duration on HIV
seropositivity, and the patient’s age had previously been
reported as prognostic factors for AIDS cholangiopathy [13,
19, 29]. However, Ko et al. identiﬁed two variables linked
to poor prognosis. One was the presence or history of any
opportunistic infection of the GI tract, lung, eye, nervous
system, skin, or of systemic involvement (hazard ratio of
3.24) or cryptosporidial infection (harzard ratio of 2.69.)
The other risk factor was a high alkaline phosphatase level
of either >1000IU/L or eight times above the upper limit of
normal (hazard ratio of 2.69). In their study, CD4 counts,
type of cholangiopathy, and sphincterotomy did not aﬀect
life expectancy. They also suggested HIV viral loads as a
possible prognostic factor, but this was unavailable for most
patients in their study [19].
Finally, it is recommended that patients with AIDS
cholangiopathyintermittentlyhaveabdominalultrasonogra-
phy and CA 19-9 levels screening for cholangiocarcinoma.
An early diagnosis might allow for complete resection of the
tumor [30].
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